Catubig, Baby Boy .

HRN: 28-73-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
AMPICILLIN 250MG (VIAL)
03/26/2026
04/02/2026
IV
130mg
Q12
PSNB
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: